FINWIRES · TerminalLIVE
FINWIRES

Southern Alliance Mining, Brazilian Critical Minerals to Explore Rare Earth Opportunities

-- Southern Alliance Mining (SGX:QNS) and Brazilian Critical Minerals (ASX:BCM), signed a non-binding agreement to evaluate opportunities for the development and distribution of rare earth products, according to a Monday filing with the Singapore Exchange.

The company owns 40% of MCRE Resources which sold around 20,280 tons of mixed rare earth carbonate as of August 2025.

Brazilian Critical Minerals on the other hand, focuses on rare earth elements and platinum group metals in Brazil.

The two parties have established a framework to assess technical, commercial and logistical requirements for potential joint ventures and to negotiate terms for future offtake arrangements.

Related Articles

Asia

Beijing Enlight Media Q1 Profit Falls 99%; Shares Down 8%

Beijing Enlight Media Co (SHE:300251) posted first-quarter attributable net profit of 23.3 million yuan, down 99% from 2.02 billion yuan the previous year.Earnings per share went down to 0.01 yuan from 0.69 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue fell 94% year over year to 190.6 million yuan from 2.97 billion yuan.Shares of the media company were down 8% in recent trade.

$SHE:300251
Asia

Enlight Media 2025 Profit Jumps 473%; Shares Fall 7%

Beijing Enlight Media (SHE:300251) posted 2025 attributable net profit of 1.67 billion yuan, up 473% from 292.0 million yuan the previous year.Earnings per share went up to 0.57 yuan from 0.10 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue jumped 155% year over year to 4.04 billion yuan from 1.59 billion yuan.Shares of the media company were down 7% in recent trade.

$SHE:300251
Asia

CR Double-Crane Pharma Gets Nod to Name Unit as Marketer of Endometriosis Drug

China Resources Double-Crane Pharmaceutical (SHA:600062) received approval from the National Medical Products Administration to change the marketing authorization holder of dienogest tablets, according to a Shanghai bourse filing on Wednesday.Under the approved supplementary application, the pharmaceutical company's subsidiary, CR Zizhu Pharmaceutical, becomes the marketing authorization holder, as well as the manufacturer of the endometriosis drug.

$SHA:600062